Abstract
We report a case of polycythemia vera with chorea in which the brain metabolism and dopamine system were investigated using 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) and 99mTc-labeled tropane dopamine transporter (99mTc-TRODAT-1) single photon emission computed tomography (SPECT). Along with normalization of the hematocrit and clinical symptoms after consecutive phlebotomies, the FDG PET scan and 99mTc-TRODAT-1 SPECT images returned towards normal. It is hypothesized that the development of polycythemia chorea is associated with a reversible alteration in the corticobasal ganglia metabolism and disturbed dopaminergic function.
Similar content being viewed by others
References
Baxter EJ, Scott LM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054–1061
Bruyn GW, Padberg G (1984) Chorea and polycythaemia. Eur Neurol 23:26–33
Etgen T, Winbeck K, Conrad B, Sander D (2003) Hemiballism with insular infarction as first manifestation of Takayasu’s arteritis in association with chronic hepatitis B. J Neurol 250:226–229
Felicio AC, Moriyama TS, Godeiro-Junior C et al (2010) Higher dopamine transporter density in Parkinson’s disease patients with depression. Psychopharmacology (Berl) 211:27–31
Frietsch T, Maurer MH, Vogel J, Gassmann M, Kuschinsky W, Waschke KF (2007) Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin over-expressing transgenic mice with excessive erythrocytosis. J Cereb Blood Flow Metab 27:469–476
Gamez J, Lorenzo-Bosquet C, Cuberas-Borros G, Carmona F, Hernandez-Vara J, Castillo J, Castell-Conesa J (2010) Does reduced [(123)I]-FP-CIT binding in Huntington’s disease suggest pre-synaptic dopaminergic involvement? Clin Neurol Neurosurg 112:870–875
Ginovart N, Lundin A, Farde L et al (1997) PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington’s disease. Brain 120(Pt 3):503–514
Huang WS, Lee MS, Lin JC, Chen CY, Yang YW, Lin SZ, Wey SP (2004) Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson’s disease. Eur J Nucl Med Mol Imaging 31:155–161
Janavs JL, Aminoff MJ (1998) Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 65:436–445
Kim W, Kim JS, Lee KS, Kim YI, Park CW, Chung YA (2008) No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI. Neurol Sci 29:351–354
Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R (1997) Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson’s disease. Ann Neurol 42:283–291
Muller-Vahl KR, Berding G, Emrich HM, Peschel T (2007) Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123)I-beta-CIT-SPECT. J Neurol 254:1081–1088
Rektorova I, Sedlackova S, Telecka S, Hlubocky A, Rektor I (2008) Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson’s disease by repetitive transcranial magnetic stimulation. Int J Biomed Imaging 2008:372125
Samuel M, Ceballos-Baumann AO, Turjanski N et al (1997) Pallidotomy in Parkinson’s disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain 120(Pt 8):1301–1313
Strafella AP, Paus T, Barrett J, Dagher A (2001) Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21:RC157
Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon
Wang GJ, Volkow ND, Levy AV, Felder CA, Fowler JS, Pappas NR, Hitzemann RJ, Wong CT (1999) Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps. J Nucl Med 40:715–720
Weeks RA, Ceballos-Baumann A, Piccini P, Boecker H, Harding AE, Brooks DJ (1997) Cortical control of movement in Huntington’s disease. A PET activation study. Brain 120(9):1569–1578
Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS (1992) Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 31:463–472
Acknowledgments
The study was supported by grants from the Department of Health, Executive Yuan, Taiwan (DOH99-TD-C-111-006), the China Medical University Hospital (DMR-99-190), and the National Science Council (NSC 99-2314-B-039-016-MY2). This study was also supported in part by the Taiwan Department of Health Clinical Trial and Research Centre of Excellence (DOH100-TD-B-111-004).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Huang, HC., Wu, YC., Shih, LY. et al. Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea. J Neurol 258, 2054–2057 (2011). https://doi.org/10.1007/s00415-011-6069-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6069-y